scPharmaceuticals Inc. to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

02/21/19

BURLINGTON, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the 8^th Annual SVB Leerink Partners Global Healthcare Conference at 1:30 p.m. ET on Thursday, February 28, 2019, at the Lotte New York Palace Hotel in New York, NY.

Investors interested in arranging a meeting with the Company’s management during this conference should contact the conference coordinator.

About scPharmaceuticals
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, products for the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit scPharmaceuticals.com.

Contacts:

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Christopher F. Brinzey
Westwicke, an ICR Company, 339-970-2843
chris.brinzey@westwicke.com